Hoppenot, D. “OMALIZUMAB: SEVERE ALLERGIC ASTHMA TREATMENT OPTION”. Pulmonology and Allergology, Vol. 2, no. 1, May 2018, pp. 68-73, doi:10.37499/PIA.201.